A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.

Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

As I prepared for my appointment, the hospital asked me to sign its registration forms and to sign up for MyChart. In the ...

Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news ...

The XBI is still up 24%, although it’s down 11% from the August high. The retreat doesn’t look that alarming relative to the ...

At the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.

Was molecular biologist David Sabatini a manipulative mentor who coerced a younger colleague into sex? Or was he the victim ...

Bipartisan legislation under review in Congress has the potential to significantly rejigger global drug development — and the biggest beneficiaries may not be American. The bill, titled the Biotech ...

In mental health care, I encountered people who believed that medication changed who they were. They didn’t mean the common ...

The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared ...

Working conditions are the larger problem. Burnout, chronic understaffing, and high turnover are among the most consistent ...